Bristol-Myers Squibb Company
NYSE: BMY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Christopher S. Boerner
- Employees
- 34,100
- Headquarters
- Princeton, United States
- IPO year
- 1972
- Market cap
- $115.3B
- Website
- https://www.bms.com
Loading BMY…
Loading profile data…Frequently asked questions about BMY
What does Bristol-Myers Squibb Company (BMY) do?
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infecti...
Where does BMY trade?
Bristol-Myers Squibb Company (BMY) trades on the New York Stock Exchange.
What sector is BMY in?
Bristol-Myers Squibb Company (BMY) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Bristol-Myers Squibb Company?
Christopher S. Boerner is the chief executive officer of Bristol-Myers Squibb Company (BMY).
Where is Bristol-Myers Squibb Company headquartered?
Bristol-Myers Squibb Company is headquartered in United States.
When did BMY go public?
Bristol-Myers Squibb Company (BMY) completed its initial public offering in 1972.